The enrichment scores of the known biological processes, such as CD8 + T effectors, FGFR3-related genes and WNT targets, were different between the distinct TET2 expression groups (Fig. S9B), which suggested the potential pathway of action of TET2 in CRC. This evidence concerns the gene TET2 and colorectal carcinoma.